These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 23490225

  • 21. The impact of treatment with indacaterol in patients with COPD: A post-hoc analysis according to GOLD 2011 categories A to D.
    Kerstjens HA, Deslée G, Dahl R, Donohue JF, Young D, Lawrence D, Kornmann O.
    Pulm Pharmacol Ther; 2015 Jun; 32():101-8. PubMed ID: 25743376
    [Abstract] [Full Text] [Related]

  • 22. Efficacy of indacaterol 75 μg once-daily on dyspnea and health status: results of two double-blind, placebo-controlled 12-week studies.
    Gotfried MH, Kerwin EM, Lawrence D, Lassen C, Kramer B.
    COPD; 2012 Dec; 9(6):629-36. PubMed ID: 23020650
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol-fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group study.
    Vogelmeier CF, Bateman ED, Pallante J, Alagappan VK, D'Andrea P, Chen H, Banerji D.
    Lancet Respir Med; 2013 Mar; 1(1):51-60. PubMed ID: 24321804
    [Abstract] [Full Text] [Related]

  • 24. Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison.
    Kornmann O, Dahl R, Centanni S, Dogra A, Owen R, Lassen C, Kramer B, INLIGHT-2 (Indacaterol Efficacy Evaluation Using 150-µg Doses with COPD Patients) study investigators.
    Eur Respir J; 2011 Feb; 37(2):273-9. PubMed ID: 20693243
    [Abstract] [Full Text] [Related]

  • 25. Indacaterol and tiotropium combination therapy in patients with chronic obstructive pulmonary disease.
    Matsushima S, Inui N, Yasui H, Kono M, Nakamura Y, Toyoshima M, Shirai T, Suda T.
    Pulm Pharmacol Ther; 2015 Feb; 30():11-5. PubMed ID: 25445929
    [Abstract] [Full Text] [Related]

  • 26. INSTEAD: a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPD.
    Rossi A, van der Molen T, del Olmo R, Papi A, Wehbe L, Quinn M, Lu C, Young D, Cameron R, Bucchioni E, Altman P.
    Eur Respir J; 2014 Dec; 44(6):1548-56. PubMed ID: 25359348
    [Abstract] [Full Text] [Related]

  • 27. Safety, tolerability and efficacy of indacaterol, a novel once-daily beta(2)-agonist, in patients with COPD: a 28-day randomised, placebo controlled clinical trial.
    Beier J, Chanez P, Martinot JB, Schreurs AJ, Tkácová R, Bao W, Jack D, Higgins M.
    Pulm Pharmacol Ther; 2007 Dec; 20(6):740-9. PubMed ID: 17088091
    [Abstract] [Full Text] [Related]

  • 28. Indacaterol 75 μg once daily for the treatment of patients with chronic obstructive pulmonary disease: a North American perspective.
    Kerwin EM, Williams J.
    Ther Adv Respir Dis; 2013 Feb; 7(1):25-37. PubMed ID: 23296242
    [Abstract] [Full Text] [Related]

  • 29. Indacaterol, a once-daily beta2-agonist, versus twice-daily beta₂-agonists or placebo for chronic obstructive pulmonary disease.
    Geake JB, Dabscheck EJ, Wood-Baker R, Cates CJ.
    Cochrane Database Syst Rev; 2015 Jan 10; 1(1):CD010139. PubMed ID: 25575340
    [Abstract] [Full Text] [Related]

  • 30. Efficacy of once-daily indacaterol relative to alternative bronchodilators in COPD: a patient-level mixed treatment comparison.
    Cope S, Capkun-Niggli G, Gale R, Lassen C, Owen R, Ouwens MJ, Bergman G, Jansen JP.
    Value Health; 2012 May 10; 15(3):524-33. PubMed ID: 22583463
    [Abstract] [Full Text] [Related]

  • 31. Acute effects of indacaterol on lung hyperinflation in moderate COPD: a comparison with tiotropium.
    Rossi A, Centanni S, Cerveri I, Gulotta C, Foresi A, Cazzola M, Brusasco V.
    Respir Med; 2012 Jan 10; 106(1):84-90. PubMed ID: 22035851
    [Abstract] [Full Text] [Related]

  • 32. QVA149 demonstrates superior bronchodilation compared with indacaterol or placebo in patients with chronic obstructive pulmonary disease.
    van Noord JA, Buhl R, Laforce C, Martin C, Jones F, Dolker M, Overend T.
    Thorax; 2010 Dec 10; 65(12):1086-91. PubMed ID: 20978028
    [Abstract] [Full Text] [Related]

  • 33. Influence of indacaterol on daily physical activity in patients with untreated chronic obstructive pulmonary disease.
    Nishijima Y, Minami S, Yamamoto S, Ogata Y, Koba T, Futami S, Komuta K.
    Int J Chron Obstruct Pulmon Dis; 2015 Dec 10; 10():439-44. PubMed ID: 25767381
    [Abstract] [Full Text] [Related]

  • 34. Efficacy and safety of indacaterol in patients with chronic obstructive pulmonary disease aged over 65 years: A pooled analysis.
    Girodet PO, Jasnot JY, Le Gros V, Decuypère L, Cao W, Devouassoux G.
    Respir Med; 2017 Jul 10; 128():92-101. PubMed ID: 28566230
    [Abstract] [Full Text] [Related]

  • 35. Sustained 24-hour efficacy of once daily indacaterol (300 μg) in patients with chronic obstructive pulmonary disease: a randomized, crossover study.
    Laforce C, Aumann J, de Teresa Parreño L, Iqbal A, Young D, Owen R, Higgins M, Kramer B, INTEGRAL Study Investigators.
    Pulm Pharmacol Ther; 2011 Feb 10; 24(1):162-8. PubMed ID: 20619353
    [Abstract] [Full Text] [Related]

  • 36. Effect of QVA149 on lung volumes and exercise tolerance in COPD patients: the BRIGHT study.
    Beeh KM, Korn S, Beier J, Jadayel D, Henley M, D'Andrea P, Banerji D.
    Respir Med; 2014 Apr 10; 108(4):584-92. PubMed ID: 24534204
    [Abstract] [Full Text] [Related]

  • 37. Indacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: a 12-week study.
    Korn S, Kerwin E, Atis S, Amos C, Owen R, Lassen C, INSIST study group.
    Respir Med; 2011 May 10; 105(5):719-26. PubMed ID: 21367594
    [Abstract] [Full Text] [Related]

  • 38. Safety and efficacy of dual bronchodilation with QVA149 in COPD patients: the ENLIGHTEN study.
    Dahl R, Chapman KR, Rudolf M, Mehta R, Kho P, Alagappan VK, Chen H, Banerji D.
    Respir Med; 2013 Oct 10; 107(10):1558-67. PubMed ID: 23867808
    [Abstract] [Full Text] [Related]

  • 39. Indacaterol therapy in patients with COPD not receiving other maintenance treatment.
    Decramer M, Rossi A, Lawrence D, McBryan D.
    Respir Med; 2012 Dec 10; 106(12):1706-14. PubMed ID: 23031496
    [Abstract] [Full Text] [Related]

  • 40. Efficacy of once-daily indacaterol 75 μg relative to alternative bronchodilators in COPD: a study level and a patient level network meta-analysis.
    Cope S, Zhang J, Williams J, Jansen JP.
    BMC Pulm Med; 2012 Jun 25; 12():29. PubMed ID: 22732017
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.